Björn Pilebro

Contact

Works as

Assistant professor, combined with clinical employment at Department of Public Health and Clinical Medicine Section: Cardiology

1A, 4tr. Målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Invasive pressure–volume loop and PET-MR phenotyping in transthyretin cardiac amyloidosis: a multimodal imaging case report

European Heart Journal - Case Reports, Oxford University Press 2026, Vol. 10, (2)

Venkateshvaran, Ashwin; Pilebro, Björn; Arvidsson, Sandra; et al.

Nexiguran ziclumeran gene editing in hereditary ATTR with polyneuropathy

New England Journal of Medicine, Massachusetts Medical Society 2025, Vol. 393, (14) : 1375-1386

Gillmore, Julian D.; Gane, Ed; Täubel, Jörg; et al.

Sixty years of experience with hereditary transthyretin amyloidosis: insights from the Swedish transthyretin amyloidosis registry

Journal of Internal Medicine, John Wiley & Sons 2025, Vol. 298 : 478-488

Stenberg, Lotta; Pilebro, Björn; Anan, Intissar; et al.

Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosis

Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2025, Vol. 20, (1)

Wixner, Jonas; Pilebro, Björn; Wien, Tale N.; et al.

Assessing left atrial dysfunction in cardiac amyloidosis using LA-LV strain slope

European Heart Journal - Imaging Methods and Practice, Oxford University Press 2024, Vol. 2, (3)

Edbom, Fredrik; Lindqvist, Per; Wiklund, Urban; et al.

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

New England Journal of Medicine, Massachussetts Medical Society 2024, Vol. 391, (23) : 2231-2241

Fontana, Marianna; Solomon, Scott D.; Kachadourian, Jessica; et al.

Echocardiographic red flags of ATTR cardiomyopathy a single centre validation

European Heart Journal. Imaging Methods and Practice, Oxford University Press 2024, Vol. 2, (3)

Henein, Michael Y.; Pilebro, Björn; Lindqvist, Per

Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2024, Vol. 31, (4) : 342-343

Pilebro, Björn; Wixner, Jonas; Anan, Intissar

Association of right ventricular myocardial blood flow with pulmonary pressures and outcome in cardiac amyloidosis

JACC Cardiovascular Imaging, Elsevier 2023, Vol. 16, (9) : 1193-1204

Harms, Hendrik J.; Clemmensen, Tor; Rosengren, Sara; et al.

Amyloid fibril composition type is consistent over time in patients with Val30Met (p. Val50Met) transthyretin amyloidosis

PLOS ONE, Public Library of Science 2022, Vol. 17, (3)

Anan, Intissar; Suhr, Ole B.; Liszewska, Katarzyna; et al.

RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis

Journal of Clinical Medicine, MDPI 2022, Vol. 11, (14)

Arnberg, Elsa; Eldhagen, Per; Löfbacka, Viktor; et al.

Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy

Heart and Vessels, Springer 2022, Vol. 37 : 1562-1569

Henein, Michael Y.; Pilebro, Björn; Lindqvist, Per

Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation

American Journal of Transplantation, John Wiley & Sons 2022, Vol. 22, (6) : 1646-1657

Schmidt, Hartmut H.; Wixner, Jonas; Planté-Bordeneuve, Violaine; et al.

Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors

Frontiers in Neurology, Frontiers Media S.A. 2022, Vol. 13

Unéus, Erica Irene; Wilhelmsson, Christer; Bäckström, David; et al.

Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic

ESC Heart Failure, John Wiley & Sons 2021, Vol. 8, (1) : 745-749

Lindmark, Krister; Pilebro, Björn; Sundström, Torbjörn; et al.

Cardiac transthyretin amyloidosis ^99mTc-DPD SPECTcorrelates with strain echocardiography and biomarkers

European Journal of Nuclear Medicine and Molecular Imaging, Springer 2021, Vol. 48 : 1822-1832

Löfbacka, Viktor; Axelsson, Jan; Pilebro, Björn; et al.

Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure

Clinical Physiology and Functional Imaging, John Wiley & Sons 2021, Vol. 41, (5) : 408-416

Löfbacka, Viktor; Suhr, Ole B.; Pilebro, Björn; et al.

Quantification of cardiac amyloid with [¹⁸F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2020, Vol. 27, (3) : 191-199

Möckelind, Sofia; Axelsson, Jan; Pilebro, Björn; et al.

Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis

Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2020, Vol. 15, (1)

Paulsson Rokke, Hedvig; Sadat Gousheh, Nima; Westermark, Per; et al.

Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type

Scandinavian Journal of Clinical and Laboratory Investigation, Taylor & Francis 2019, Vol. 79, (6) : 372-376

Hellman, Urban; Lång, Kenneth; Ihse, Elisabet; et al.

Prevalence of transthyretin cardiac amyloidosis in a community-based heart failure population

European Heart Journal, Oxford University Press 2019, Vol. 40 : 132-132

Lindmark, Krister; Pilebro, Björn; Solekrans, L.; et al.

Visualisation of amyloid deposition within the brain of long-term hereditary transthyretin amyloidosis survivors by 18F-flutemetamol positron emission tomography

European Journal of Neurology, John Wiley & Sons 2019, Vol. 26, (S1) : 287-287

Unéus, Erica; Wilhelmsson, Christer; Suhr, Ole; et al.

The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis Group 2019, Vol. 26 : 39-40

Wixner, Jonas; Westermark, Per; Ihse, Elisabet; et al.

Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2018, Vol. 25, (1) : 46-53

Henein, Michael Y.; Suhr, Ole B.; Arvidsson, Sandra; et al.

Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)

Journal of Nuclear Cardiology, Springer 2018, Vol. 25, (1) : 240-248

Pilebro, Björn; Arvidsson, Sandra; Lindqvist, Per; et al.

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients

Transplantation, LIPPINCOTT WILLIAMS & WILKINS 2018, Vol. 102, (2) : e59-e66

Wange, Niklas; Anan, Intissar; Ericzon, Bo-Göran; et al.

The heart in hereditary transthyretin amyloidosis: clinical studies on the impact of amyloid fibril composition

Umeå University medical dissertations, 1904

Pilebro, Björn

The Swedish landscape of hereditary ATTR amyloidosis

Amyloid: Journal of Protein Folding Disorders, Vol. 24, (1) : 93-94

Suhr, Ole B; Wixner, Jonas; Pilebro, Björn; et al.

Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Vol. 24, (1) : 78-79

Wixner, Jonas; Pilebro, Bjorn; Lundgren, Hans-Erik; et al.

Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy

International Journal of Cardiology, Elsevier 2016, Vol. 212 : 47-53

Henein, Michael; Arvidsson, Sandra; Pilebro, Björn; et al.

^99mTC-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis

Upsala Journal of Medical Sciences, Taylor & Francis 2016, Vol. 121, (1) : 17-24

Pilebro, Björn; Suhr, Ole B.; Näslund, Ulf; et al.

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition

PLOS ONE, Vol. 10, (11)

Arvidsson, Sandra; Pilebro, Björn; Westermark, Per; et al.

European Journal of Heart Failure, Vol. 17 : 64-65

Gustavsson, Sandra; Pilebro, Björn; Westermark, P.; et al.

Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: a n-of-1 trial series pilot study

Håkansson, Erik; Anan, Intissar; Brunström, Mattias; et al.

Design and rationale of the ULRICA trial: using dapagliflozin to reduce symptoms and improve walking distance in transthyretin cardiac amyloidosis

Håkansson, Erik; Pilebro, Björn; Lindmark, Krister

Electrocardiographic features of hereditary V30M transthyretin amyloidosis, different phenotypes with similar findings

Pilebro, Björn; Suhr, Ole B; Ihse, Elisabeth; et al.

View publications in DiVA

Research projects

1 January 2019

Pathogenesis, diagnostics and treatment of transthyretin amyloidosis

Published: 17 Jan, 2025

From the Umeå lab to around the world – how genetic scissors are now being used